Diet and Cancer

Slide 1 · Diet and Cancer

Environmental exposures • Carcinogenic mechanisms • Evidence appraisal

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Interpret geographic and migration evidence without inferring a single dietary cause.

Distinguish exogenous carcinogens from compounds formed from dietary precursors.

Explain proposed colorectal, gastric, and hepatocellular carcinogenic mechanisms.

Appraise nutritional prevention claims and the obesity–cancer connection.

Slide 3 · Diet may modify cancer risk

Dietary exposure

Biological interaction

Tissue-level effects

Cancer occurrence

Diet is one environmental influence among many.

A plausible mechanism is not equivalent to demonstrated human causation.

Unresolved links between specific diets and tumors.

Slide 4 · Cancer incidence differs across populations

Site-specific cancer incidence varies markedly by geographic region.

Differences reaching as much as 100-fold.

Variation invites examination of environmental, dietary, and other influences.

A geographic contrast alone does not identify which exposure is causal.

Slide 5 · Migration offers a natural comparison

Original population

Migration

Changed environment

Altered incidence

Progressively higher colon cancer occurrence among Japanese populations moving to Hawaii and then the continental United States.

The pattern supports environmental modifiability but does not isolate diet.

Slide 6 · Colon cancer incidence changed in Japan

Substantial temporal increases in Japanese populations.

An incidence pattern is not necessarily fixed by ancestry.

Changing diet is a possible contributor within a broader environmental transition.

Specific causal dietary components remain uncertain.

Slide 7 · What population comparisons can establish

Supported inference

Cancer rates are modifiable.

Environment matters alongside inherited susceptibility.

Diet is a reasonable exposure to investigate.

Not established

A specific nutrient is the sole cause.

An observed food pattern has a proven mechanism.

A particular diet prevents cancer in an individual.

Slide 8 · Why nutrition epidemiology is difficult

Problem

Consequence

Interpretation

Correlated exposures

Diet travels with other behaviors

Confounding can persist

Long latency

Past intake may be uncertain

Exposure timing matters

Multiple pathways

One cancer has many influences

Single-cause stories mislead

Changing populations

Incidence reflects several shifts

Temporal inference is limited

Slide 9 · Three dietary concerns in carcinogenesis

Exogenous agents

Endogenous formation

Missing protection

Carcinogens may be ingested already formed.

Dietary constituents can yield reactive substances inside the body.

Low intake of putative protective components may be relevant.

Slide 10 · Distinguish the three exposure pathways

Category

Representative concept

Evidence caveat

External carcinogen

Aflatoxin exposure

Strong molecular association with HCC

Formed in vivo

Nitroso compounds from precursors

Animal evidence; Human relevance uncertain

Putative protection

Fiber and antioxidants

Mechanisms often inconsistent or unproven

Slide 11 · Aflatoxin is a dietary carcinogenic exposure

Aflatoxin is discussed by Robbins as an exogenous food-related carcinogen.

It contributes to hepatocellular carcinoma in parts of Asia and Africa.

The relationship is often observed together with hepatitis B virus infection.

This example links an environmental exposure to a specific molecular change.

Slide 12 · Aflatoxin and hepatocellular carcinoma

Aflatoxin exposure

DNA damage / mutation

Selected cellular clones

Hepatocellular cancer

The source identifies a characteristic mutation affecting TP53 codon 249.

Mutation is a mechanistic signature, not a stand-alone clinical diagnosis.

Slide 13 · Aflatoxin and hepatitis B: Two contributors

Aflatoxin

Diet-associated exogenous agent

Linked to a characteristic TP53 alteration

Relevant to hepatocellular carcinoma

Hepatitis B virus

Infectious carcinogenic factor

Often coexists in implicated settings

Shows that dietary and nondietary risks interact

Slide 14 · Codon 249 of TP53 is a molecular clue

A specific TP53 codon 249 mutation is associated with aflatoxin exposure.

It as a molecular signature in relevant liver tumors.

The alteration connects exposure biology with tumor molecular pathology.

It should not be interpreted as a universal feature of hepatocellular carcinoma.

Slide 15 · Exposure signature is not a screening test

What the signature supports

A link between mutagenic exposure and tumor biology

Mechanistic specificity in an appropriate setting

Interpretation at the population or tumor level

What it does not prove

That all affected tumors share the same mutation

That a mutation alone identifies clinical exposure history

That TP53 mutation is sufficient for cancer

Slide 16 · Interpret chemical-additive concerns cautiously

Debate over the carcinogenicity of food additives.

Artificial sweeteners are included among the debated exposures.

The textbook does not establish that these agents cause human cancers.

Avoid conflating a theoretical concern with an established cancer risk.

Slide 17 · Food contaminants versus dietary constituents

External agents

Examples include aflatoxin and debated contaminants.

The candidate carcinogen may be present before ingestion.

Exposure definition is central.

Dietary precursors

Compounds are formed after ingestion.

Gut chemistry and microbial activity may intervene.

Dose, host, and context influence plausibility.

Slide 18 · Nitroso compounds are a gastric cancer hypothesis

Nitrosamines and nitrosamides in gastric carcinogenesis.

Such compounds induce gastric cancer in experimental animals.

They may arise through endogenous reactions involving dietary components.

Animal carcinogenicity does not directly quantify human dietary risk.

Slide 19 · Nitrosation combines different dietary precursors

Nitrite

Amines or amides

Nitroso compounds

Potential DNA injury

Protein digestion supplies amine or amide precursors.

Nitrites can participate in chemical formation of nitrosamines or nitrosamides.

This as a potential contributor to gastric cancer.

Slide 20 · Food preservation provides one nitrite source

Sodium nitrite can be added to certain foods as a preservative.

Dietary nitrite can enter the chemical pathway toward N-nitroso compounds.

Presence of a precursor does not establish that a carcinogenic dose forms.

Do not equate a single preserved food with a cancer diagnosis.

Slide 21 · Dietary nitrate may become nitrite

Dietary nitrate

Bacterial reduction

Nitrite

Possible nitrosation

Vegetables can contain nitrates.

Gut bacterial flora can reduce nitrates to nitrites.

This pathway describes chemistry, not proof that vegetables cause cancer.

Slide 22 · Protein digestion contributes amine substrates

Digestion can yield amines or amides from dietary proteins.

These substrates may react with nitrite to form N-nitroso compounds.

Both precursor availability and conditions for formation are relevant.

Mechanistic diagrams must not imply a known cancer risk per meal.

Slide 23 · Proposed endogenous route to gastric carcinogenesis

Dietary precursors

Gut / host chemistry

N-nitroso compounds

Potential gastric effect

The causal link is plausible because some formed compounds are carcinogenic in animals.

Human diet–gastric cancer causation is not established by this pathway alone.

Slide 24 · Animal experiments and human causality

Experimental finding

Certain nitroso compounds cause gastric tumors in animals.

Demonstrates biological carcinogenic potential.

Controls exposure more directly.

Human uncertainty

Real dietary precursor conversion varies.

Dietary associations are prone to confounding.

No individual risk estimate follows from animal results.

Slide 25 · Avoid attributing gastric cancer to one compound

Robbins frames endogenous formation as a possible contributor.

Tumor development cannot be inferred merely from exposure to nitrates or nitrites.

An experimentally active agent may not be generated at relevant human levels.

The distinction between concern and demonstrated cause is essential.

Slide 26 · Colorectal cancer: An implicated dietary pattern

High animal-fat intake combined with low fiber intake.

The pattern has been implicated in colon carcinogenesis.

Several mechanistic explanations have been proposed.

The textbook explicitly notes inconsistent validation of these explanations.

Slide 27 · Proposed pathway from fat intake to bile acids

High fat intake

Increased intestinal bile acids

Changed intestinal milieu

Possible mucosal exposure

Higher bile acid levels in the gut are proposed as a link between dietary fat and colorectal cancer.

This is an explanatory hypothesis, not a proven linear human pathway.

Slide 28 · Bile acids may reshape intestinal flora

Bile acid changes

Flora selection

Microaerophilic bacteria

Bile acid metabolites

Preferential growth of certain microaerophilic bacteria.

Bacterial metabolism may generate compounds with carcinogenic potential.

Slide 29 · Bile acid metabolites are candidate mediators

Bacteria may transform bile acids into secondary metabolites.

Some metabolites have been proposed to act as carcinogens.

A microbial intermediary supplies mechanistic plausibility.

Clinical and experimental evidence has not consistently confirmed the full chain.

Slide 30 · Mechanism proposed; Clinical proof incomplete

Mechanistic narrative

Fat alters intraluminal bile acid conditions.

Bacterial composition or activity changes.

Metabolites may affect colorectal mucosa.

Evidentiary limitation

The complete chain has not been consistently reproduced.

Dietary association does not identify the mediator.

Do not portray arrows as proven human causal estimates.

Slide 31 · Fiber increases stool bulk

Dietary fiber can increase fecal mass.

More bulk may dilute potentially harmful intraluminal substances.

The proposed protective mechanism also involves shortening transit time.

A physical mechanism should not be mistaken for established chemoprevention.

Slide 32 · Fiber and mucosal contact time

Fiber intake

Greater stool bulk

Shorter transit time

Less mucosal contact

Reduced duration of exposure to putative luminal carcinogens.

The key intermediate is contact time, not a direct antitumor action.

Slide 33 · Certain fibers might bind luminal carcinogens

Another proposed mechanism is direct binding of carcinogens.

Binding would reduce access of reactive molecules to colorectal mucosa.

The effect likely depends on fiber type and chemical context.

No consistent clinical or experimental confirmation.

Slide 34 · Two hypothesized benefits of fiber

Bulk

Higher fecal mass

Potential dilution

Transit

Reduced residence time

Potentially less contact

Binding

Sequestration of some molecules

Potentially less mucosal access

Uncertainty

Proposed mechanisms

Not consistently validated

Slide 35 · Evaluate the colorectal diet hypothesis

Proposed link

Possible mediator

Strength of conclusion

Animal fat → colon risk

Bile acids / microbiota

Implicated; Not firmly causal

Microbiota → mucosal injury

Bile acid metabolites

Biologically plausible

Fiber → protection

Bulk / transit / binding

Inconsistent mechanism studies

Exposure → cancer

Multiple long-term factors

Not reducible to one nutrient

Slide 36 · Historical fiber-risk estimate needs context

An estimate that intake near 40 g/day could halve colon cancer risk.

This estimate is presented in a discussion of proposed protective effects.

Robbins immediately notes inconsistent confirmation of relevant theories.

Do not present the historical figure as an individualized or established risk reduction.

Slide 37 · Association is not a dosing recommendation

What was reported

An estimated effect of increasing population fiber intake.

A proposed link between bulk, transit, and carcinogen contact.

A topic warranting investigation.

What remains unresolved

Causal magnitude in humans

Applicability to different populations and fibers

A universal therapeutic target for cancer prevention

Slide 38 · Antioxidants are a prevention hypothesis

Reactive oxidant injury provides a rationale for antioxidant protection.

Vitamins C and E, β-carotene, and selenium.

Their antioxidant properties motivated chemoprevention hypotheses.

Biological plausibility alone is insufficient to establish benefit.

Slide 39 · Putative antioxidant micronutrients

Vitamin C

Antioxidant activity

Not proven as chemopreventive

Vitamin E

Antioxidant activity

Not proven as chemopreventive

β-Carotene

Antioxidant-associated rationale

No convincing preventive evidence here

Selenium

Antioxidant-associated rationale

No convincing preventive evidence here

Slide 40 · Nutritional adequacy versus supplementation

Nutritional concept

Micronutrients have physiological functions.

Dietary adequacy and cancer prevention are different questions.

Associations can prompt research.

Chemoprevention claim

Requires evidence that intake reduces cancer incidence.

Antioxidant action is not sufficient evidence.

Robbins finds no convincing prevention benefit.

Slide 41 · Antioxidant chemoprevention is unproven

Robbins does not find convincing evidence for preventive effects.

A proposed anticarcinogenic mechanism cannot replace clinical outcomes.

Do not imply vitamin supplementation reliably prevents malignancy.

Treatment indications elsewhere cannot validate a prevention claim.

Slide 42 · Retinoids in acute promyelocytic leukemia

The efficacy of retinoids in treating acute promyelocytic leukemia.

This is a therapeutic oncology application.

It does not establish that dietary antioxidant supplements prevent cancer.

Treatment of an established neoplasm and primary prevention are distinct endpoints.

Slide 43 · Vitamin D: Observation is not intervention

Low measured vitamin D

Observed cancer association

Hypothesis generation

Causal study needed

Associations with cancers of the colon, prostate, and breast.

The text does not establish that vitamin D supplementation prevents these tumors.

Slide 44 · Vitamin D associations: Two possible readings

Association observed

Low vitamin D levels occur with some cancers.

A potential biological relationship can be studied.

This observation has no necessary intervention effect.

Other explanations

Confounding by behaviors or disease states

Reverse causality or correlated risk factors

Other unmeasured determinants

Slide 45 · Diet and obesity are related but not identical

Dietary composition and body adiposity are distinct exposures.

Obesity-associated cancer immediately before this section.

Obesity may alter hormones, metabolism, and inflammatory signaling.

Benefits of a healthy dietary pattern should not be equated with proven effects of a single food.

Slide 46 · Cancer sites linked to obesity

Gastrointestinal

Hormone-responsive

Additional sites

Esophagus / upper stomach

Endometrium

Kidney

Colon / rectum

Breast

Meningioma

Gallbladder / liver

Ovary

Multiple myeloma

Pancreas

—

—

Slide 47 · Insulin resistance can increase growth signaling

Obesity

Insulin resistance

Hyperinsulinemia / free IGF-1

Growth signaling

IGF-1 receptor signaling to RAS and PI3K/AKT pathways.

This is one proposed contributor, not a sole explanation for obesity-associated cancers.

Slide 48 · Adiposity alters sex-steroid availability

Obesity

Altered hormone production

Lower SHBG / increased estrogen availability

Growth regulation

Estrogen synthesis from androgen precursors and lower hepatic SHBG.

These changes are relevant to hormone-responsive tissues.

Slide 49 · Adiponectin: A proposed protective signal

Adiponectin secretion decreases in obesity.

Antiproliferative and pro-apoptotic actions.

The proposed links include promotion of p53 and p21 activity.

Reduced signaling could weaken antineoplastic influences.

Slide 50 · Chronic inflammation is another candidate link

Excess adiposity

Proinflammatory state

Altered tissue signaling

Possible tumor promotion

Obesity-associated inflammation as a possible carcinogenic mechanism.

The cancer relationship is likely multifactorial.

Slide 51 · No single obesity–cancer mechanism explains all sites

Systemic mediators

Insulin / IGF-1 signaling

Steroid-hormone changes

Adiponectin reduction

Local and contextual effects

Chronic inflammation

Cancer-site differences

Long duration and degree of adiposity

Slide 52 · Weight-loss drugs: An open cancer question

GLP-1 agonists as an area of interest for future research.

Their possible effects on obesity-associated cancer incidence remain to be determined in this source.

Weight reduction is not equivalent to established pharmacologic cancer prevention.

Do not claim a protective cancer outcome from a question still under study.

Slide 53 · Rank the strength of textbook claims

Claim

What the source supports

Avoid saying

Aflatoxin → HCC

Recognized contributor; TP53 signature

Every HCC has that mutation

Nitroso compounds → gastric cancer

Animal carcinogenicity; Possible human route

Processed food uniquely causes gastric cancer

Fiber → reduced colon cancer

Proposed protective mechanisms

Specific fiber dose reliably halves risk

Antioxidants → prevention

Plausibility; No convincing prevention proof

Supplements prevent cancer

Slide 54 · How to appraise a diet–cancer claim

Observe association

Specify exposure

Test a mechanism

Check human outcomes

Distinguish correlation, biological plausibility, and intervention effects.

Ask whether cancer incidence—not merely a biomarker—was assessed.

Keep uncertainty visible in conclusions.

Slide 55 · Applied interpretation: An HCC mutation

Clinical / reasoning prompt

An HCC contains a TP53 alteration at codon 249. The clinical team asks whether this establishes aflatoxin exposure.

Interpretation

This mutation is a molecular signature associated with aflatoxin.

It supports etiologic interpretation in context, but is not a complete exposure history.

Consider viral and other carcinogenic influences.

Slide 56 · Applied interpretation: Gastric carcinogens

Clinical / reasoning prompt

A proposed preventive message states: “All nitrate-containing vegetables cause gastric cancer.” How should the evidence be assessed?

Interpretation

Reject the conclusion: Nitrate can be converted to nitrite, which may form nitroso compounds.

The pathway does not demonstrate that eating vegetables causes gastric cancer.

Distinguish precursor chemistry from human causal effects.

Slide 57 · Applied interpretation: Colorectal fiber

Clinical / reasoning prompt

A patient reads that increasing fiber to 40 g/day will cut personal colon cancer risk by 50%. What is the defensible response?

Interpretation

The number is a historical estimate cited, not an individual prognostic calculation.

Proposed benefits involve stool bulk, transit, or binding.

Mechanistic studies have produced inconsistent results.

Slide 58 · Applied interpretation: Vitamin supplementation

Clinical / reasoning prompt

A person asks whether antioxidant supplements reliably prevent cancer. Another asks about low vitamin D levels and malignancy.

Interpretation

Robbins finds no convincing chemopreventive evidence for named antioxidants.

Low vitamin D–cancer associations do not demonstrate prevention by supplementation.

Do not conflate anticancer therapy with nutritional prevention.

Slide 59 · Prevention message: Proportionate to evidence

Avoid certainty that a particular diet alone causes or prevents cancer.

A healthy diet that helps prevent obesity is a reasonable general-health strategy.

Be explicit when discussing speculative chemical or microbial mechanisms.

Keep the cancer-prevention claim separate from other health benefits.

Slide 60 · Integrated diet–cancer mechanism map

Domain

Main exemplar

Inference boundary

External exposure

Aflatoxin / TP53 codon 249

Molecular signature in HCC

Internal synthesis

Nitrosamines / nitrosamides

Gastric hypothesis; Animal evidence

Local intestinal milieu

Fat–bile acids–microbiota

Proposed CRC mediator

Missing protective factor

Fiber / antioxidants

Inconsistent or nonconvincing human evidence

Energy regulation

Obesity-associated pathways

Multifactorial cancer association

Slide 61 · Final synthesis

Diet enters carcinogenesis through exposures, chemical formation, and putative protection.

Aflatoxin provides a relatively specific exposure–mutation–tumor example.

Nitrosation, bile-acid conversion, and fiber protection remain mechanistically plausible but incompletely demonstrated.

Nutrient supplementation should not be recommended as proven anticancer chemoprevention.

Slide 62 · Selected reference

Robbins, Cotran & Kumar: Pathologic Basis of Disease

11th edition (2026)

Chapter 9: Environmental and Nutritional Diseases

“Diet and Cancer,” p. 409; related “Obesity and Cancer,” pp. 408–409.